- Home
- ZONE vs KALA Comparison
ZONE vs KALA Comparison
Compare ZONE & KALA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZONE
- KALA
- Stock Information
- Founded
- ZONE 2022
- KALA 2009
- Country
- ZONE United States
- KALA United States
- Employees
- ZONE N/A
- KALA N/A
- Industry
- ZONE
- KALA Biotechnology: Pharmaceutical Preparations
- Sector
- ZONE
- KALA Health Care
- Exchange
- ZONE NYSE
- KALA Nasdaq
- Market Cap
- ZONE 19.3M
- KALA 26.2M
- IPO Year
- ZONE 2024
- KALA 2017
- Fundamental
- Price
- ZONE $3.11
- KALA $5.70
- Analyst Decision
- ZONE
- KALA Strong Buy
- Analyst Count
- ZONE 0
- KALA 3
- Target Price
- ZONE N/A
- KALA $14.00
- AVG Volume (30 Days)
- ZONE 62.3K
- KALA 137.8K
- Earning Date
- ZONE 05-14-2025
- KALA 08-05-2025
- Dividend Yield
- ZONE N/A
- KALA N/A
- EPS Growth
- ZONE N/A
- KALA N/A
- EPS
- ZONE N/A
- KALA N/A
- Revenue
- ZONE $1,887,046.00
- KALA N/A
- Revenue This Year
- ZONE N/A
- KALA N/A
- Revenue Next Year
- ZONE N/A
- KALA N/A
- P/E Ratio
- ZONE N/A
- KALA N/A
- Revenue Growth
- ZONE 38.12
- KALA N/A
- 52 Week Low
- ZONE $0.81
- KALA $2.92
- 52 Week High
- ZONE $5.54
- KALA $11.20
- Technical
- Relative Strength Index (RSI)
- ZONE N/A
- KALA 59.39
- Support Level
- ZONE N/A
- KALA $5.39
- Resistance Level
- ZONE N/A
- KALA $6.30
- Average True Range (ATR)
- ZONE 0.00
- KALA 0.63
- MACD
- ZONE 0.00
- KALA 0.03
- Stochastic Oscillator
- ZONE 0.00
- KALA 56.00
About ZONE CLEANCORE SOLUTIONS INC
CleanCore Solutions Inc engages in the development and manufacturing of cleaning products that produce pure aqueous ozone for professional, industrial, or home use. The firm has a patented nanobubble technology using aqueous ozone that is effective in cleaning, sanitizing, and deodorizing surfaces and high-touch areas. The company offers products and solutions that are marketed for janitorial and sanitation, ice machine cleaning, laundry, and industrial industries. Its products are used in many types of environments including retail establishments, distribution centers, factories, warehouses, restaurants, schools and universities, airports, healthcare, food service, and commercial buildings such as offices, malls, and stores.
About KALA KALA BIO Inc.
Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.